Stem Cell Therapeutics Receives U.S. Orphan Drug Designation

News   Nov 01, 2013

 
Stem Cell Therapeutics Receives U.S. Orphan Drug Designation
 
 
 

RELATED ARTICLES

How Bone Marrow Niches Keep Stem Cells Thriving

News

Japanese researchers uncover cellular factor needed to maintain the environment that regulates hematopoietic stem cells.

READ MORE

Reversing an Unstoppable Cancer Cascade with Proteomics

News

Mutations in genes that produce RAS proteins turn a normally benign process, essential for cellular growth, into a cancer stimulant that is currently undruggable. Now, cutting-edge protein analysis may help treat cancers caused by these mutations.

READ MORE

Grafted Brain Organoids Provide Insight into Neurological Disorders

News

Salk scientists improve the growth of three-dimensional brain models to better understand autism, dementia, schizophrenia.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE